ストックスクリーナーアプリを入手
11.91
3.01%
-0.37
前日終値:
$12.28
開ける：
$12.28
24時間の取引高:
927.01K
Relative Volume:
0.68
時価総額：
$1.04B
収益：
-
当期純損益:
$-185.15M
株価収益率:
-5.8806
EPS:
-2.0253
ネットキャッシュフロー:
$-148.72M
1週間 パフォーマンス:
-5.78%
1か月 パフォーマンス:
+21.28%
6か月 パフォーマンス:
-57.59%
1年 パフォーマンス:
+145.57%
1日の値動き範囲:
$11.43
$12.28
1週間の範囲:
$11.43
$13.09
52週間の値動き範囲:
$4.37
$36.26
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
Compare OLMA vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
11.91 | 1.04B | 0 | -185.15M | -148.72M | -2.0253 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | Wolfe Research | Peer Perform |
| 2026-03-19 | 再開されました | Jefferies | Buy |
| 2026-02-11 | 開始されました | Stifel | Buy |
| 2026-01-07 | 開始されました | Piper Sandler | Overweight |
| 2025-10-08 | 開始されました | Guggenheim | Buy |
| 2025-08-12 | 繰り返されました | Citigroup | Buy |
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Enterprise value to EBIT forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Price to earnings forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Price to earnings forward of Olema Pharmaceuticals, Inc. – BOATS:OLMA - TradingView
Price to book forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
OLMA News | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) - ChartMill
Enterprise value to EBITDA forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Enterprise value to EBITDA forward of Olema Pharmaceuticals, Inc. – BOATS:OLMA - TradingView
Enterprise value to revenue forward of Olema Pharmaceuticals, Inc. – NASDAQ:OLMA - TradingView
Olema Pharmaceuticals (OLMA) Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesInvestor Earnings Call - dars.gov.et
LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $24 - Moomoo
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Oncology awards 215,800 options to eight new employees - Stock Titan
Olema Pharmaceuticals opens director clinical science role to advance cancer trial programs - Traders Union
Olema Pharmaceuticals (OLMA) Is Up 22.0% After Broad Russell Growth Index InclusionHas The Bull Case Changed? - simplywall.st
Does Olema Pharmaceuticals' (OLMA) Broad Russell Growth Inclusion Reveal a Turning Point in Its Investor Story? - Yahoo Finance
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS: OLMA) added to Russell 2500 Growth Benchmark - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS: OLMA) added to Russell 2000 Growth Benchmark - marketscreener.com
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to Russell 3000E Growth Benchmark - marketscreener.com
Olema Pharmaceuticals (OLMA) Holds Steady Near Support Amid Minor DeclineUp Down Volume - dars.gov.et
Olema Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:OLMA) - TradingView
OLMA Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Olema Pharmaceuticals Inc For: 23 June By Investing.com - Investing.com Australia
Olema (NASDAQ: OLMA) awards director 29,500 stock options - Stock Titan
BVF group (NASDAQ: OLMA) reports 29,500 new options and large pre-funded warrants - Stock Titan
Olema (NASDAQ: OLMA) director receives grant of 29,500 stock options at $9.51 - Stock Titan
Olema Pharmaceuticals (OLMA) director awarded 29,500 stock options at $9.51 strike price - Stock Titan
Olema (OLMA) director Garland J. Scott awarded 29,500 stock options at $9.51 - Stock Titan
[Form 4] Olema Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Olema Pharmaceuticals (OLMA) director granted 29,500 stock options at $9.51 strike - Stock Titan
Olema (OLMA) director receives 29,500 options at $9.51 strike price - Stock Titan
Olema (OLMA) director granted 29,500 stock options at $9.51 exercise price - Stock Titan
Olema (NASDAQ: OLMA) director granted 29,500 stock options at $9.51 strike price - Stock Titan
Olema (OLMA) director Graham Walmsley awarded 29,500 stock options at $9.51 - Stock Titan
Olema Pharmaceuticals (NASDAQ: OLMA) investors approve board slate, pay plan and Ernst & Young - Stock Titan
What Prompted the Chief Legal Officer's Recent OLMA Share Sales - Kavout
Olema Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Olema Pharmaceuticals Inc (OLMA) Institutional Confidence - TradingKey
Olema Pharmaceuticals Inc (OLMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Olema Pharmaceuticals Inc (OLMA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Olema Pharmaceuticals Inc (OLMA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Olema Pharmaceuticals Inc (OLMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Olema Pharmaceuticals Inc (OLMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet - Insider Monkey
10 Small Cap Stocks with Potential to Rise 1000 Percent - Insider Monkey
OLMA Stock Soars 47% in September So Far on Second PFE Deal - MSN
OLMA,GH Options - Finviz
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Olema Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating - Moomoo
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):